Clinical trials are essential to assess both the efficacy and safety of new pharmaceuticals, medical devices and other health care-related products. In recent years, the use of remote/decentralized clinical trials has slowly grown alongside the technology that enables their application. The COVID-19 pandemic created an environment to drive the exponential growth of these alternatives to traditional, site-based clinical trials so that trials in progress could continue and trials with imminent start dates could commence.